Microbix Biosystems (MBXBF) 0.4350 $MBXBF
Microbix Signs Virology Distribution Agreement for South Korea
Marketwired - Thu Apr 02, 7:31AM CDT
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"

, an innovator of biological products and technologies, announced today it has signed an exclusive distribution agreement with Kim & Friends, Inc. ("K&F"

. With more than 1,500 healthcare customers in South Korea, K&F is recognized for providing strong scientific and technical support. The agreement provides Microbix with improved access to the key South Korean market for its virology products.
MBX.TO: 0.52 (unch)
Microbix Announces First Molecular Diagnostics Agreement
Marketwired - Tue Mar 31, 8:04AM CDT
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"

, an innovator of biological products and technologies, announced today that it has entered into a long-term agreement with St. Cloud, Minnesota-based Microbiologics, Inc. ("Microbiologics"

, a leading developer of biological controls and standards, pursuant to which Microbix will provide specialized viral material which will be incorporated into a line of full process controls, including instrument-specific sets, under Microbiologics' Helix Elite(TM) Molecular Standards brand.
MBX.TO: 0.52 (unch)
Microbix Lawsuit in Germany Dismissed Without Prejudice
Marketwired - Thu Mar 26, 8:29AM CDT
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"

, an innovator of biological products and technologies, announced today that the Court of Dusseldorf, Germany has dismissed its VIRUSMAX(R) patent infringement lawsuit against Novartis Vaccines and Diagnostics ("Novartis"

without prejudice.
MBX.TO: 0.52 (unch), NVS: 103.58 (+1.01)
Microbix Announces New Product Launches in Field of Molecular Diagnostics
Marketwired - Mon Mar 02, 5:42AM CST
Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"

, an innovator of biological products and technologies, today announced new Molecular Diagnostics ("MDx"

product launches and provided an update on several important initiatives in its Virology Products business.
MBX.TO: 0.52 (unch)
Microbix Reports Virology Revenue Up 8% in First Quarter
Marketwired - Fri Feb 13, 7:31AM CST
Microbix Biosystems Inc. (TSX: MBX), an innovator of biological products and technologies, today reported financial results for its first quarter ending December 31, 2014.
MBX.TO: 0.52 (unch)
IIROC Trade Resumption - Microbix Biosystems Inc.
Newsfile Corp - Fri Aug 22, 12:57PM CDT
Trading resumes in:
IIROC Trade Halt - Microbix Biosystems Inc.
Newsfile Corp - Fri Aug 22, 12:17PM CDT
The following issues have been halted by IIROC: